Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abiko, Y., Jinbu, Y., Noguchi, T., Nishimura, M., Kusano, K., Amaratunga, P., Shibata, T., and Kaku, T. (2002). Upregulation of human betadefensin 2 peptide expression in oral lichen planus, leukoplakia and candidiasis an immunohistochemical study. Pathol. Res. Pract. 198: 537–542.
Arendorf, T.M. and Walker, D.M. (1980). The prevalence and intra-oral distribution of Candida albicans in man. Arch. Oral Biol. 25: 1–10.
Baev, D., Li, X.S., Dong, J., Keng, P., and Edgerton, M. (2002). Human salivary histatin 5 causes disordered volume regulation and cell cycle arrest in Candida albicans. Infect. Immun. 70: 4777–4784.
Balish, E., Wagner, R.D., Vazquez-Torres, A., Pierson, C., and Warner, T. (1998). Candidiasis in interferon-gamma knockout (IFN-gamma-/-) mice. J. Infect. Dis. 78: 478–487.
Belazi, M., Fleva, A., Drakoulakos, D., and Panayiotidou, D. (2002). Salivary IgA and serum IgA and IgG antibodies to Candida albicans in HIV-infected subjects. Int. J. STD AIDS 13: 373–377.
Bistoni, F., Cenci, E., Mencacci, A., Schiaffella, E., Mosci, P., Puccetti, P., and Romani, L. (1993). Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans. J. Infect. Dis. 168: 1449–1457.
Borg, M., Watters, D., Reich, B. and Rüchel, R. (1988). Production and characterization of monoclonal antibodies against secretory proteinase of Candida albicans CBS 2730. Zbl. Bakteriol. Hyg. A. 268: 62–73.
Bromuro, C., Torosantucci, A., Chiani, P., Conti, S., Polonelli, L., and Cassone, A. (2002). Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine. Infect. Immun. 70: 5462–5470.
Budtz-Jorgensen, E. (1973). Immune response to Candida albicans in monkeys with experimental candidiasis in the palate. Scand. J. Dent. Res. 81: 360–371.
Challacombe, S. (1991). Revised classification of HIV-associated oral lesions. Br. Dent. J. 170: 305–306.
Challacombe, S.J. and Sweet, S.P. (1997). Salivary and mucosal immune responses to HIV and its co-pathogens. Oral Dis. 3(Suppl. 1): S79–S84.
Cheng, S., Nguyen, M.H., Zhang, Z., Jia, H., Handfield, M., and Clancy, C.J. (2003). Evaluation of the roles of four Candida albicans genes in virulence by using gene disruption strains that express URA3 from the native locus. Infect. Immun. 71: 6101–6103.
Conti, S., Magliani, W., Arseni, S., Frazzi, R., Salati, A., Ravanetti, L., and Polonelli, L. (2002). Inhibition by yeast killer toxin-like antibodies of oral Streptococci adhesion to tooth surfaces in an ex vivo model. Mol. Med. 8: 313–317.
Coogan, M.M. and Challacombe, S.J. (2000). Serum and salivary antibodies to a mycobacterial 65-kDa stress protein are elevated in HIV-positive patients and modified by oral candidiasis. Oral Microbiol. Immunol. 15: 284–289.
Coogan, M.M., Sweet, S., and Challacombe S.J. (1994). Immunoglobulin A (IgA), IgA1 and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus (HIV) infection and AIDS. Infect. Immun. 62: 892–896.
De Bernardis, F., Boccanera, M., Adriani, D., Spreghini, E., Santoni, G., and Cassone, A. (1997). Protective role of antimannan and antiaspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect. Immun. 65: 3399–3405.
De Bernardis, F., Arancia, S., Morelli, L., Hube, B., Sanglard, D., Schafer, W., and Cassone, A. (1999). Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis. J. Infect. Dis. 179: 201–208.
Dongari-Bagtzoglou, A. and Kashleva, H. (2003). Granulocyte-macrophage colony-stimulating factor responses of oral epithelial cells to Candida albicans. Oral Microbiol. Immunol. 18: 165–170.
Dorko, E., Jenca, A., Pilipcinec, E., and Tkacikova, L. (2002). Detection of anti-Candida antibodies by the indirect immunofluorescence assay in patients with cancer in the orofacial region. Folia Microbiol. (Praha) 47: 732–736.
Drobacheff, C., Millon, L., Monod, M., Piarroux, R., Robinet, E., Laurent, R., and Meillet, D. (2001). Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis. Clin. Chem. Lab Med. 39: 519–526.
Edgerton, M., Koshlukova, S.E., Lo, T.E., Chrzan, B.G., Straubinger, R.M., and Raj, P.A. (1998). Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J. Biol. Chem. 273: 20438–20447.
Edgerton, M., Koshlukova, S.E., Araujo, M.W., Patel, R.C., Dong, J., and Bruenn, J.A. (2000). Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. Antimicrob. Agents Chemother. 44: 3310–3316.
Elahi, S., Pang, G., Clancy, R., and Ashman, R.B. (2000). Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis. Infect. Immun. 68: 5771–5777.
Farah, C.S., Hong, S., Wanasaengsakul, S., Elahi, S., Pang, G., Gotjamanos, T., Seymour, G.J., Clancy, R.L., and Ashman, R.B. (2001a). Irradiation-induced oral candidiasis in an experimental murine model. Oral Microbiol. Immunol. 16: 358–363.
Farah, C.S., Elahi, S., Pang, G., Gotjamanos, T., Seymour, G.J., Clancy, R.L., and Ashman, R.B. (2001b). T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis. Infect. Immun. 69: 6110–6118.
Farah, C.S., Elahi, S., Drysdale, K., Pang, G., Gotjamanos, T., Seymour, G.J., Clancy, R.L., and Ashman, R.B. (2002a). Primary role for CD4(+) T lymphocytes in recovery from oropharyngeal candidiasis. Infect. Immun. 70: 724–731.
Farah, C.S., Gotjamanos, T., Seymour, G.J., and Ashman, R.B. (2002b). Cytokines in the oral mucosa of mice infected with Candida albicans. Oral Microbiol. Immunol. 17: 375–378.
Fellermann, K. and Stange, E.F. (2001) Defensins—innate immunity at the epithelial frontier. Eur. J. Gastroenterol. Hepatol. 13: 771–776.
Fidel, P.L. Jr., Lynch, M.E., and Sobel, J.D. (1995a). Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect. Immun. 63: 2403–2408.
Fidel, P.L. Jr., Lynch, M.E., Conaway, D.H., Tait, L., and Sobel, J.D. (1995b). Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity. Infect. Immun. 63: 547–553.
Garcia, Y.H., Diez, S.G., Aizpun, L.T., and Oliva, N.P. (2002). Antigliadin antibodies associated with chronic mucocutaneous candidiasis. Pediatr. Dermatol. 19: 415–418.
Ghadjari, A., Matthews, R.C., and Burnie, J.P. (1997). Epitope mapping Candida albicans proteinase (SAP 2). FEMS Immunol. Med. Microbiol. 19: 115–123.
Holmes, A.R., Bandara, B.M., and Cannon, R.D. (2002). Saliva promotes Candida albicans adherence to human epithelial cells. J. Dent. Res. 81: 28–32.
Hube, B. (2000). Extracellular proteinases of human pathogenic fungi. Contrib. Microbiol. 5: 126–137.
Hube, B., Sanglard, D., Odds, F.C., Hess, D., Monod, M., Schafer, W., Brown, A.J., and Gow, N.A. (1997). Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect. Immun. 65: 3529–3538.
Intini, G., Aguirre, A., and Bobek, L.A. (2003). Efficacy of human salivary mucin MUC7-derived peptide and histatin 5 in a murine model of candidiasis. Int. J. Antimicrob. Agents 22: 594–600.
Ivanyi, L. and Ivanyi, J. (1990). Elevated antibody levels to mycobacterial 65-kDa stress protein in patients with superficial candidiasis. J. Infect. Dis. 162: 519–522.
Johansson, I., Bratt, P., Hay, D.I., Schluckebier, S., and Stromberg, N. (2000). Adhesion of Candida albicans, but not Candida krusei, to salivary statherin and mimicking host molecules. Oral Microbiol. Immunol. 15: 112–118.
Kantardjiev, T.V. and Popova, E.V. (2002). Anti-Candida antibodies in serum and saliva of patients with denture stomatitis. Folia Med. (Plovdiv.) 44: 39–44.
Kostiala, A.A., Jormalainen, S., and Kosunen, T.U. (1979). Detection of experimental bacteremia and fungemia by examination of buffy coat prepared by a micromethod. Am. J. Clin. Pathol. 72: 437–443.
Kozel, T.R., MacGill, R.S., Percival, A., and Zhou, Q. (2004). Biological activities of naturally occurring antibodies reactive with Candida albicans mannan. Infect. Immun. 72: 209–218.
Kurnatowski, P. and Kurnatowska, A.J. (1999). Fungi of Candida species in the pharynx and some parameters of humoral and cellular immunity in patients. Panminerva Med. 41: 149–151.
Lehner, T. (1970). Serum fluorescent antibody and immunoglobulin estimations in candidosis. J. Med. Microbiol. 3: 475–481.
Lehner, T., Wilton, J.M., and Ivanyi, L. (1972). Immunodeficiencies in chronic muco-cutaneous candidosis. Immunology 22: 775–787.
Leigh, J.E., Barousse, M., Swoboda, R.K., Myers, T., Hager, S., Wolf, N.A., Cutright, J.L., Thompson, J., Sobel, J.D., and Fidel, P.L. Jr. (2001). Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis. J. Infect. Dis. 183: 277–285.
Leigh, J.E., Steele, C., Wormley, F., and Fidel, P.L. Jr. (2002). Salivary cytokine profiles in the immunocompetent individual with Candida-associated denture stomatitis. Oral Microbiol. Immunol. 17: 311–314.
Macdonald, F. and Odds, F.C. (1980). Purified Candida albicans proteinase in the serological diagnosis of systemic candidosis. JAMA 243: 2409–2411.
Matthews, R.C., Burnie, J.P., and Tabaqchali, S. (1987). Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J. Clin. Microbiol. 25: 230–237.
Millon, L., Drobacheff, C., Piarroux, R., Monod, M., Reboux, G., Laurent, R., and Meillet, D. (2001). Longitudinal study of anti-Candida albicans mucosal immunity against aspartic proteinases in HIV-infected patients. J. Acquir. Immune Defic. Syndr. 1 26: 137–144.
Montagnoli, C., Bozza, S., Bacci, A., Gaziano, R., Mosci, P., Morschhauser, J., Pitzurra, L., Kopf, M., Cutler, J., and Romani, L. (2003). A role for antibodies in the generation of memory antifungal immunity. Eur. J. Immunol. 33: 1193–1204.
Moragues, M.D., Omaetxebarria, M.J., Elguezabal, N., Sevilla, M.J., Conti, S., Polonelli, L., and Ponton, J. (2003). A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities. Infect. Immun. 71: 5273–5279.
Myers, T.A., Leigh, J.E., Arribas, A.R., Hager, S., Clark, R., Lilly, E., and Fidel, P.L. Jr. (2003). Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis. Infect. Immun. 71: 956–963.
Na, B.-K., Chung, G.-T., and Song, C.-Y. (1999). Production, characterisation and epitope mapping of a monoclonal antibody against aspartic proteinase of Candida albicans. Clin. Diag. Lab. Immunol. 6: 429–433.
Naglik, J.R., Newport, G., White, T.C., Fernandes-Naglik, L.L., Greenspan, J.S., Greenspan, D., Sweet, S.P., Challacombe, S.J., and Agabian, N. (1999). In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infect. Immun. 67: 2482–2490.
Naglik, J.R., Rodgers, C.A., Shirlaw, P.J., Dobbie, J.L., Fernandes-Naglik, L.L., Greenspan, D., Agabian, N., and Challacombe, S.J. (2003a). Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections. J. Infect. Dis. 188: 469–79.
Naglik, J.R., Challacombe, S.J., and Hube, B. (2003b). Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev. 67: 400–428.
Naglik, J.R., Scott, J., Rahman, D., Mistry, M., and Challacombe, S.J. (2005). Serum and saliva antibodies do not inhibit Candida albicans Sap2 proteinase activity using a BSA hydrolysis assay. Med. Mycol. 43: 73–77.
Netea, M.G., Van der Graaf, C.A., Vonk, A.G., Verschueren, I., Van der Meer, J.W., and Kullberg, B.J. (2002). The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J. Infect. Dis. 185: 1483–1489.
Netea, M.G., Sutmuller, R., Hermann, C., Van der Graaf, C.A., Van der Meer, J.W., van Krieken, J.H., Hartung, T., Adema, G., and Kullberg, B.J. (2004). Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172: 3712–3718.
Nikawa, H., Jin, C., Makihira, S., Hamada, T., and Samaranayake, L.P. (2002). Susceptibility of Candida albicans isolates from the oral cavities of HIV-positive patients to histatin-5. J. Prosthet. Dent. 88: 263–267.
Nomanbhoy, F., Steele, C., Yano, J., and Fidel, P.L. Jr. (2002). Vaginal and oral epithelial cell anti-Candida activity. Infect. Immun. 70: 7081–7088.
Odds, F.C. and Webster, C.E. (1988). Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections. J. Antimicrob. Chemother. 22: 473–481.
Palmer, D.A., Boardman, B., and Bauchner, H. (1996). Sixth and eighth graders and acquired immunodeficiency syndrome: the results of focus group analysis. J. Adolesc. Health 19: 297–302.
Pivarcsi, A., Bodai, L., Rethi, B., Kenderessy-Szabo, A., Koreck, A., Szell, M., Beer, Z., Bata-Csorgoo, Z., Magocsi, M., Rajnavolgyi, E., Dobozy, A., and Kemeny, L. (2003). Expression and function of toll-like receptors 2 and 4 in human keratinocytes. Int. Immunol. 15: 721–730.
Polonelli, L., Gerloni, M., Conti, S., Fisicaro, P., Cantelli, C., Portincasa, P., Almondo, F., Barea, P.L., Hernando, F.L., and Ponton, J. (1994). Heat-shock mannoproteins as targets of secretory IgA in Candida albicans. J. Infect. Dis. 69: 1401–1405.
Polonelli, L., Magliani, W., Conti, S., Bracci, L., Lozzi, L., Neri, P., Adriani, D., De Bernardis, F., and Cassone, A. (2003). Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis. Infect. Immun. 71: 6205–6212.
Rahman, D. and Challacombe, S.J. (1995). Oral immunization against mucosal candidiasis in a mouse model. Adv. Exp. Med. Biol. 371B: 1663–1666.
Rodier, M.H., Imbert, C., Kauffmann-Lacroix, C., Daniault, G., and Jacquemin, J.L. (2003). Immunoglobulins G could prevent adherence of Candida albicans to polystyrene and extracellular matrix components. J. Med. Microbiol. 52: 373–377.
Roeder, A., Kirschning, C.J., Rupec, R.A., Schaller, M., and Korting, H.C. (2004). Toll-like receptors and innate antifungal responses. Trends Microbiol. 12: 44–49.
Romani, L., Mocci, S., Cenci, E., Rossi, R., Puccetti, P., and Bistoni, F. (1991a). Candida albicans-specific Ly-2+ lymphocytes with cytolytic activity. Eur. J. Immunol. 21: 1567–1570.
Romani, L., Mocci, S., Bietta, C., Lanfaloni, L., Puccetti, P., and Bistoni, F. (1991b). Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect. Immun. 59: 4647–4654.
Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Mosci, P., Puccetti, P., and Bistoni, F. (1993). CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J. Immunol. 150: 925–931.
Romani, L., Mencacci, A., Cenci, E., Puccetti, P., and Bistoni, F. (1996). Neutrophils and the adaptive immune response to Candida albicans. Res. Immunol. 147: 512–518.
Romani, L., Bistoni, F., and Puccetti, P. (1997a). Initiation of T-helper cell immunity to Candida albicans by IL-12: the role of neutrophils. Chem. Immunol. 68: 110–135.
Romani, L., Mencacci, A., Cenci, E., Del Sero, G., Bistoni, F., and Puccetti, P. (1997b). An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. J. Immunol. 158: 2356–2362.
Romani, L., Bistoni, F., and Puccetti, P. (1997c). Initiation of T-helper cell immunity to Candida albicans by IL-12: the role of neutrophils. Chem. Immunol. 68: 110–135.
Rouabhia, M., Ross, G., Page, N., and Chakir, J. (2002). Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation. Infect. Immun. 70: 7073–7080.
Rüchel, R. and Boning, B. (1983). Detection of Candida proteinase by enzyme immunoassay and interaction of the enzyme with alpha-2-macroglobulin. J. Immunol. Meth. 61: 107–116.
Rüchel, R., Boning-Stutzer, B., and Mari, A. (1988). A synoptical approach to the diagnosis of candidosis, relying on serological antigen and antibody tests, on culture, and on evaluation of clinical data. Mycoses 31: 87–106.
Saavedra, M., Taylor, B., Lukacs, N., and Fidel, P.L. Jr. (1999). Local production of chemokines during experimental vaginal candidiasis. Infect. Immun. 67: 5820–5826.
Sanglard, D., Hube, B., Monod, M., Odds, F.C., and Gow, N.A. (1997). A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect. Immun. 65: 3539–3546.
San-Millan, R., Elguezabal, N., Regulez, P., Moragues, M.D., Quindos, G., and Ponton, J. (2000). Effect of salivary secretory IgA on the adhesion of Candida albicans to polystyrene. Microbiology 146: 2105–2112.
Sawaki, K., Mizukawa, N., Yamaai, T., Fukunaga, J., and Sugahara, T. (2002). Immunohistochemical study on expression of alpha-defensin and beta-defensin-2 in human buccal epithelia with candidiasis. Oral Dis. 8: 37–41.
Schaller, M., Korting, H.C., Schafer, W., Bastert, J., Chen, W., and Hube, B. (1999). Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol. Microbiol. 34: 169–180.
Shi, J., Zhang, G., Wu, H., Ross, C., Blecha, F., and Ganz, T. (1999). Porcine epithelial betadefensin 1 is expressed in the dorsal tongue at antimicrobial concentrations. Infect. Immun. 67: 3121–3127.
Steele, C. and Fidel, P.L. Jr. (2002) Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect. Immun. 70: 577–583.
Steele, C., Ozenci, H., Luo, W., Scott, M., and Fidel, P.L. Jr. (1999). Growth inhibition of Candida albicans by vaginal cells from naive mice. Med. Mycol. 37: 251–259.
Steele, C., Leigh, J., Swoboda, R., Ozenci, H., and Fidel, P.L. Jr. (2001). Potential role for a carbohydrate moiety in anti-Candida activity of human oral epithelial cells. Infect. Immun. 69: 7091–7099.
Sullivan, D.J., Westerneng, T.J., Haynes, K.A., Bennett, D.E., and Coleman, D.C. (1995). Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141: 1507–1521.
Sweet, S.P., Cookson, S., and Challacombe, S.J. (1995). Candida albicans isolates from HIV-infected and AIDS patients exhibit enhanced adherence to epithelial cells. J. Med. Microbiol. 43: 452–457.
Swoboda, R., Miyasaki, S., Greenspan, D., and Greenspan, J.S. (1993). Heat-inducible ATP-binding proteins of Candida albicans are recognized by sera of infected patients. J. Gen. Microbiol. 139: 2995–3003.
Tollemar, J., Gross, N., Dolgiras, N., Jarstrand, C., Ringden, O., and Hammarstrom, L. (1999). Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients. Bone Marrow Transplant. 23: 283–290.
Triebel, T., Grillhosl, B., Kacani, L., Lell, C.P., Fuchs, A., Speth, C., Lass-Florl, C., Steinmann, J., Dierich, M.P., and Wurzner, R. (2003). Importance of the terminal complement components for immune defence against Candida. Int. J. Med. Microbiol. 292: 527–536.
Valdimarsson, H., Higgs, J.M., Wells, R.S., Yamamura, M., Hobbs, J.R., and Holt, P.J. (1973). Immune abnormalities associated with chronic mucocutaneous candidiasis. Cell Immunol. 6: 348–361.
van Wyk, C.W. and van der, B.P. (1994). Retention of acquired resistance to C. albicans by mice during short term immunosuppression. J. Dent. Assoc. S. Afr. 49: 15–20.
Wagner, R.D, Vazquez, T.A, Jones, C.J, Warner, T., and Balish, E. (1996). B Cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis. J. Infect. Dis. 174: 589–597.
Watts, H.J., Cheah, F.S., Hube, B., Sanglard, D., and Gow, N.A. (1998). Altered adherence in strains of Candida albicans harbouring null mutations in secreted aspartic proteinase genes. FEMS Microbiol. Lett. 159: 129–135.
Wellington, M., Bliss, J.M., and Haidaris, C.G. (2003). Enhanced phagocytosis of Candida species mediated by opsonization with a recombinant human antibody single-chain variable fragment. Infect. Immun. 71: 7228–7231.
Wozniak, K.L., Leigh, J.E., Hager, S., Swoboda, R.K., and Fidel, P.L. Jr. (2002). A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis. J. Infect. Dis. 185: 1269–1276.
Yeh, C.K., Dodds, M.W., Zuo, P., and Johnson, D.A. (1997). A population-based study of salivary lysozyme concentrations and candidal counts. Arch. Oral Biol. 42: 25–31.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Challacombe, S.J., Rahman, D., Mistry, M., Naglik, J.R. (2005). Humoral Factors in the Protection of the Oral Cavity against Candidiasis. In: Fidel, P.L., Huffnagle, G.B. (eds) Fungal Immunology. Springer, Boston, MA. https://doi.org/10.1007/0-387-25445-5_3
Download citation
DOI: https://doi.org/10.1007/0-387-25445-5_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-24092-3
Online ISBN: 978-0-387-25445-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)